Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
具有21个氨基酸遗传密码的非自然生物的开发与应用
基本信息
- 批准号:10640232
- 负责人:
- 金额:$ 37.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAmino Acyl-tRNA SynthetasesAnabolismAntibodiesBiochemicalCellsCollectionDevelopmentEnzymesEukaryotic CellEvolutionFluorescence-Activated Cell SortingGenerationsGenetic CodeGenetically Modified OrganismsGoalsImmunologic ReceptorsLibrariesMedicineMetabolicModern MedicineNucleotidesOrganismPathway interactionsProkaryotic CellsProliferatingProtein BiosynthesisProteinsResearchSiteSpecificityStructureTherapeuticTransfer RNATranslationsTreatment EfficacyTriplet Multiple BirthVaccinesVariantantibody conjugatebiological systemschimeric antigen receptordesignenzyme activityimmunoengineeringinterestmutantnext generationnovelnovel therapeuticspreventprogramstherapeutic developmenttherapeutic proteintherapy developmenttool
项目摘要
PROJECT SUMMARY/ABSTRACT
In most organisms, the genetic code, consisting of 64 triplets of nucleotides, encodes 20 amino acid building
blocks used in the synthesis of proteins. The overall goal of the PI’s research program is to develop
interdisciplinary tools to reprogram the genetic code to precisely probe and manipulate biological systems.
Central to reprogramming the genetic code is our ability to add noncanonical amino acids (ncAAs) to proteins of
interest. The overall goal of this proposal is to develop cells able to biosynthesize and utilize ncAAs and explore
the utility or these unnatural organisms in protein evolution and therapy development. To achieve this goal, the
first research direction will focus on the generation of completely autonomous organisms with a variety of 21st
amino acids. The prokaryotic and eukaryotic cells with the 21st amino acid will harbor a biosynthetic pathway and
a bioorthogonal aminoacyl-tRNA synthetase (aaRS)/tRNA pair for the new amino acid building block. The
biosynthesis pathway of ncAAs will be obtained from other species or via metabolic repurposing. To site-
specifically incorporate these ncAAs into proteins, we will evolve bioorthogonal aaRS/tRNA pairs and add them
to the cells. The resulting organisms with a 21st amino acids will allow for the evolution of proteins with novel
activities as well as the development of new therapies. To evolve novel or enhanced enzyme activity not
accessible by the 20 canonical amino acids, a library of ncAA-containing enzyme mutants will be generated in
the unnatural organisms and subjected to a fluorescence-activated cell sorting (FACS)-based or survival
selection. The evolved ncAA-dependent enzymes can be used to prevent the unintended proliferation of
genetically modified organisms or to prepare autotrophic vaccines. Next, we will explore the utility of these
unnatural organisms with additional protein building blocks for therapeutic development. The prokaryotic and
eukaryotic cells able to biosynthesize and utilize amino acids with bioorthogonal handles will be used to produce
antibody variants with optimized therapeutic efficacy. Engineered immune cells with additional building blocks
will allow for the redirection of the specificity of chimeric antigen receptor (CAR)-immune cells, thus providing a
new design strategy for switchable CAR-immune cells. Our efforts in this project will yield a collection of
organisms with additional amino acids building blocks, and will result in versatile platforms for ncAA-based
protein evolution or therapeutic proteins that could revolutionize modern medicine.
项目摘要/摘要
在大多数生物体中,遗传密码由64个核苷酸组成,编码20个氨基酸建筑物
用于合成蛋白质的块。 PI研究计划的总体目标是开发
跨学科工具将通用代码重新编程为精确探测和操纵生物系统。
重编程通用代码的中心是我们将非规范氨基酸(NCAA)添加到蛋白质的能力
兴趣。该提案的总体目标是开发能够生物合成和利用NCAA并探索的细胞
蛋白质进化和治疗开发中的效用或这些不自然的生物。为了实现这一目标,
第一个研究方向将集中于以各种第21的全部自主生物的产生
氨基酸。 21氨基酸的原核和真核细胞将带有生物合成途径,并且
新型氨基酸构建块的生物正交氨基酰基-TRNA合成酶(AARS)/TRNA对。这
NCAA的生物合成途径将从其他物种或通过代谢重新定位获得。到现场 -
特别将这些NCAA纳入蛋白质中,我们将进化生物正交的AARS/tRNA对并添加它们
到细胞。带有21氨基酸的生物生物可以使蛋白质与新颖
活动以及新疗法的发展。进化新颖或增强的酶活性而不是
可以通过20个规范氨基酸来访问,将在含NCAA的酶突变体的库中产生
不自然的组织,并受到荧光激活的细胞分选(FACS)的基础或存活
选择。进化的NCAA依赖性酶可用于防止意外的增殖
转基因的生物或制备自养疫苗。接下来,我们将探索这些效用
不自然的生物具有其他蛋白质构建块,用于治疗性发育。原核生物和
真核细胞可以和使用生物正交手柄的氨基酸来生产
具有优化治疗有效性的抗体变体。具有其他构件的工程免疫细胞
将允许重定向嵌合抗原受体(CAR) - 免疫细胞的特异性,从而提供了
可开关的CAR-MMUNE细胞的新设计策略。我们在这个项目中的努力将产生
带有其他氨基酸的生物体,并将为基于NCAA的多功能平台提供多功能平台
蛋白质进化或可以彻底改变现代医学的蛋白质。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Single-Atom Switching as a General Approach to Designing Colorimetric and Fluorogenic Probes for Mercury Ions.
- DOI:10.1016/j.dyepig.2020.109014
- 发表时间:2020-11
- 期刊:
- 影响因子:0
- 作者:A. Loredo;Lushun Wang;Shichao Wang;Han Xiao
- 通讯作者:A. Loredo;Lushun Wang;Shichao Wang;Han Xiao
Tetrazine as a general phototrigger to turn on fluorophores.
- DOI:10.1039/d0sc01009j
- 发表时间:2020-05-07
- 期刊:
- 影响因子:8.4
- 作者:Loredo A;Tang J;Wang L;Wu KL;Peng Z;Xiao H
- 通讯作者:Xiao H
ZipA Uses a Two-Pronged FtsZ-Binding Mechanism Necessary for Cell Division.
- DOI:10.1128/mbio.02529-21
- 发表时间:2021-12-21
- 期刊:
- 影响因子:6.4
- 作者:Cameron TA;Vega DE;Yu C;Xiao H;Margolin W
- 通讯作者:Margolin W
Site-Specific Incorporation of a Photoactivatable Fluorescent Amino Acid.
- DOI:10.1002/cbic.202000602
- 发表时间:2021-02-02
- 期刊:
- 影响因子:0
- 作者:Tang J;Yu C;Loredo A;Chen Y;Xiao H
- 通讯作者:Xiao H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Han Xiao其他文献
Han Xiao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Han Xiao', 18)}}的其他基金
Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis
调节骨中的表观遗传靶标来治疗乳腺癌转移
- 批准号:
10736034 - 财政年份:2023
- 资助金额:
$ 37.84万 - 项目类别:
Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion
利用遗传密码扩展开发针对尤文肉瘤的骨靶向抗体
- 批准号:
10600106 - 财政年份:2021
- 资助金额:
$ 37.84万 - 项目类别:
Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion
利用遗传密码扩展开发针对尤文肉瘤的骨靶向抗体
- 批准号:
10383663 - 财政年份:2021
- 资助金额:
$ 37.84万 - 项目类别:
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
具有21个氨基酸遗传密码的非自然生物的开发与应用
- 批准号:
10433887 - 财政年份:2019
- 资助金额:
$ 37.84万 - 项目类别:
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
具有21个氨基酸遗传密码的非自然生物的开发与应用
- 批准号:
10194550 - 财政年份:2019
- 资助金额:
$ 37.84万 - 项目类别:
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
具有21个氨基酸遗传密码的非自然生物的开发与应用
- 批准号:
9797768 - 财政年份:2019
- 资助金额:
$ 37.84万 - 项目类别:
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
具有21个氨基酸遗传密码的非自然生物的开发与应用
- 批准号:
10002259 - 财政年份:2019
- 资助金额:
$ 37.84万 - 项目类别:
相似海外基金
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
具有21个氨基酸遗传密码的非自然生物的开发与应用
- 批准号:
10194550 - 财政年份:2019
- 资助金额:
$ 37.84万 - 项目类别:
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
具有21个氨基酸遗传密码的非自然生物的开发与应用
- 批准号:
10433887 - 财政年份:2019
- 资助金额:
$ 37.84万 - 项目类别:
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
具有21个氨基酸遗传密码的非自然生物的开发与应用
- 批准号:
9797768 - 财政年份:2019
- 资助金额:
$ 37.84万 - 项目类别:
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
具有21个氨基酸遗传密码的非自然生物的开发与应用
- 批准号:
10002259 - 财政年份:2019
- 资助金额:
$ 37.84万 - 项目类别: